Joseph Visit 2: A 52-year-old African-American male with hypertension and erectile dysfunction


Joseph Visit 2: A 52-year-old African-American male with hypertension and erectile dysfunction

Topic: Cardiology
Relevant Terms: Atherosclerosis, Cardiometabolic Risk, Cardiovascular Disease, Erectile Dysfunction, Lipid Disorders, Metabolic Syndrome, Sexual Dysfunction
Primary Audience: Pharmacists, Physician Assistants, Physicians; Nurses and Registered Dietitians.
Launch Date: 04-May-10
Credits: 0.5 AMA PRA Category 1 Credit
0.5 ACPE contact hour
0.5 ANCC contact hour
0.5 CDR continuing professional education unit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Management of Dyslipidemia

Learning Objectives

Upon completion of the activity, participants should be able to:

  1. Apply evidence-based strategies for the prevention, screening, and treatment of atherosclerosis risk factors and their comorbidities to clinical practice
  2. Evaluate current and novel markers for atherosclerosis and their potential applications for CV risk detection and management, as well as their limitations
  3. Optimize treatment strategies utilizing dose titration and combination therapy that may support better clinical outcomes
  4. Incorporate appropriate treatment strategies for special risk populations, including minorities and women
  5. Implement effective behavioral modification and counseling strategies to encourage patient compliance to therapies


    Peter H. Jones, MD, FNLA
    Associate Professor of Medicine
    Section of Atherosclerosis and Lipid Research
    Methodist Debakey Heart and Vascular Center
    Baylor College of Medicine
    Center for Cardiovascular Disease Prevention
    Director, Weight Management Center
    The Methodist Hospital
    Houston, TX
    James Underberg, MD, MS, FACPM, FACP, FNLA
    Clinical Assistant Professor of Medicine 
    NYU Medical School 
    Director, Primary Care Lipid Management Clinic
    Bellevue Hospital Lipid Clinic
    New York, New York
    This continuing education activity is sponsored by the National Lipid Association and AKH Inc., Advancing Knowledge in Healthcare.

    Target Audience
    This activity is designed to meet the educational needs of physicians, physician assistants, pharmacists, nurses and registered dietitians interested in lipid management.

    Course Viewing Requirements
    Learning Media — online asynchronous learning activity.
    Internet Explorer (v6 or greater), or Firefox

    CME credit provided by the National Lipid Association.
    The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation
    The National Lipid Association designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

    CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

    AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 0.5 continuing professional education units (CPEUs) for completion of this program/material. CDR Accredited Provider #AN008. The focus of this activity is rated Level 2. Learners may submit evaluations of program/materials quality to the CDR at

    AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.

    AKH Inc. designates this educational activity for 0.5 contact hours (0.05 CEU). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
    AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc. approves this knowledge-based activity for 0.5 contact hours (0.05 CEU). UAN 0077-9999-10-011-H01-P.

    To Obtain CME and CE Credits This activity includes text and graphics and may include multimedia features. Click on all of the medical education activity links and review the content presented. This activity should take approximately 30 minutes to complete.

    • Read, complete, and submit answers to the examination and evaluation questions online.
    • To receive credit for this activity you must answer all case and post-assessment questions.
    • Once you have completed the examination and evaluation, a certificate will be automatically generated.

    Faculty Disclosure Statement
    The National Lipid Association and AKH Inc. adhere to ACCME essential areas and policies, and ACPE and ANCC standards. Disclosure of faculty and commercial relationships, if any, are listed below. Identified conflicts are resolved prior to the certification of the activity. 

    NLA and AKH staff planners and reviewers have no relevant financial relationships to disclose.

    Peter H. Jones, MD, FNLA :
    . Speakers Bureau: Abbott Laboratories, Inc., AstraZeneca, Daiichi Sankyo, and Merck & Co.
    · Advisory Board: AstraZeneca and Merck & Co.
    . Consultant:  Abbott Laboratories, Inc. and Roche

    James Underberg, MD, MS, FACPM, FACP, FNLA:
    · Speakers Bureau:
    Abbott Labs, AstraZeneca, DiaDexus, Daiichi Sankyo, Forest Labs, GlaxoSmithKline, Kowa Pharmaceuticals America, Inc., LipoScience, Inc., Merck & Co., and Novartis
    · Consultant:  LipoScience, Inc.
    , AstraZeneca, GlaxoSmithKline, Liposcience, Takeda, Merck-ScheringPlough
    Unlabeled and Investigational Usage
    The participant is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

    Commercial Support
    This continuing education activity is supported by educational grants from AstraZeneca, and Merck/Schering-Plough Pharmaceuticals Inc.

    ADA Compliance
    In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities.

    The material presented at or in any National Lipid Association (NLA) continuing education activity does not necessarily reflect the views and opinions of the NLA or AKH Inc. Neither NLA, AKH Inc, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

    To contact the CME/CE provider, click here.